Can calcium channel blockers prevent ischemic stroke in nonvalvular atrial fibrillation patients?-the optimal choice of antihypertensive drug for subtype-specific stroke prevention

Hypertens Res. 2022 Jun;45(6):1076-1078. doi: 10.1038/s41440-022-00907-2. Epub 2022 Apr 1.

Authors

Takuya Kiyohara¹, Tetsuro Ago²

Affiliations

¹ Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
² Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. [email protected].

PMID: 35365798
DOI: 10.1038/s41440-022-00907-2

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / adverse effects
Antihypertensive Agents / therapeutic use
Atrial Fibrillation* / chemically induced
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Calcium Channel Blockers / therapeutic use
Humans
Ischemic Stroke*
Risk Factors
Stroke* / chemically induced
Stroke* / prevention & control

Substances

Anticoagulants
Antihypertensive Agents
Calcium Channel Blockers